Seminars in Nuclear Medicine
Volume 36, Issue 4 , Pages 267-274 , October 2006

Single-Photon Emission Computed Tomography/Computed Tomography in Endocrinology

  • Yodphat Krausz, MD

      Affiliations

    • Department of Medical Biophysics and Nuclear Medicine, Hadassah–Hebrew University Medical Center, Jerusalem, Israel.
    • Corresponding Author InformationAddress reprint requests to Yodphat Krausz, MD, Department of Medical Biophysics and Nuclear Medicine, Hadassah–Hebrew University Medical Center, Ein-Kerem, Jerusalem 91120, Israel.
    • ,
  • Ora Israel, MD

      Affiliations

    • Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel.
    • Faculty of Medicine, Israel Institute of Technology–Technion, Haifa, Israel.

References 

  1. Bocher M , Balan A , Krausz Y , et al.   Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images . Eur J Nucl Med . 2000;27:619–627
  2. von Schulthess GK , Pelc NJ . Integrated-modality imaging: the best of both worlds . Acad Radiol . 2002;9:1241–1244
  3. Keidar Z , Israel O , Krausz Y . SPECT/CT in tumor imaging: technical aspects and clinical applications . Semin Nucl Med . 2003;33:205–218
  4. Schillaci O . Hybrid SPECT/CT: a new era for SPECT imaging? . Eur J Nucl Med Mol Imaging . 2005;32:521–524
  5. van der Lely AJ , de Herder WW , Krenning EP , et al.   Octreoscan radioreceptor imaging . Endocrine . 2003;20:307–311
  6. Noone TC , Hosey J , Firat Z , et al.   Imaging and localization of islet-cell tumours of the pancreas on CT and MRI . Best Pract Res Clin Endocrinol Metab . 2005;19:195–211
  7. Krenning EP , Kwekkeboom DJ , Bakker WH , et al.   Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients . Eur J Nucl Med . 1993;20:716–731
  8. Krausz Y , Bar-Ziv J , de Jong RB , et al.   Somatostatin receptor scintigraphy in the management of gastroenteropancreatic tumors . Amer J Gastroenterol . 1998;93:66–70
  9. Bombardieri E , Maccauro M , De Deckere E , et al.   2001 Nuclear medicine imaging of neuroendocrine tumours . Ann Oncol . 2001;12(suppl 2):S51–S61
  10. Kwekkeboom DJ , Krenning EP . Somatostatin receptor imaging . Semin Nucl Med . 2002;32:84–91
  11. Otte A , Mueller-Brand J , Dellas S , et al.   Yttrium-90-labelled somatostatin-analog for cancer treatment . Lancet . 1998;351:417–418
  12. De Jong M , Breeman WA , Bernard HF , et al.   Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogs . Q J Nucl Med . 1999;43:356–366
  13. De Jong M , Valkema R , Jamar F , et al.   Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings . Semin Nucl Med . 2002;32:133–140
  14. Lebtahi R , Cadiot G , Sarda L , et al.   Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors . J Nucl Med . 1997;38:853–858
  15. Termanini B , Gibril F , Reynolds JC , et al.   Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management . Gastroenterology . 1997;112:335–347
  16. de Jong M , Breeman WA , Valkema R , et al.   Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs . J Nucl Med . 2005;46(suppl 1):13S–17S
  17. Gibril F , Reynolds JC , Chen CC , et al.   Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas . J Nucl Med . 1999;40:539–553
  18. Forster GJ , Laumann C , Nickel O , et al.   SPET/CT image co-registration in the abdomen with a simple and cost-effective tool . Eur J Nucl Med Mol Imaging . 2003;30:32–39
  19. Perault C , Schvartz C , Wampach H , et al.   Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas . J Nucl Med . 1997;38:1234–1242
  20. Even-Sapir E , Keidar Z , Sachs J , et al.   The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms . J Nucl Med . 2001;42:998–1004
  21. Krausz Y , Keidar Z , Kogan I , et al.   SPECT/CT hybrid imaging with In111-Pentetreotide in assessment of Neuroendocrine Tumors . Clin Endocrinol . 2003;59:565–573
  22. Pfannenberg AC , Eschmann SM , Horger M , et al.   Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms . Eur J Nucl Med Mol Imaging . 2003;30:835–843
  23. Schillaci O . Functional-anatomical image fusion in neuroendocrine tumors . Cancer Biother Radiopharm . 2004;19:129–134
  24. Pacak K , Linehan WM , Eisenhofer G , et al.   Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma . Ann Intern Med . 2001;134:315–329
  25. Freitas JE . Adrenal cortical and medullary imaging . Semin Nucl Med . 1995;25:235–250
  26. Mozley PD , Kim CK , Mohsin J , et al.   The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma . J Nucl Med . 1994;35:1138–1144
  27. Fujita A , Hyodoh H , Kawamura Y , et al.   Use of fusion images of 131I metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma . Clin Nucl Med . 2000;25:440–442
  28. Ozer S , Dobrozemsky G , Kienast O , et al.   Value of combined XCT/SPECT technology for avoiding false positive planar 123I-MIBG scintigraphy . Nuklearmedizin . 2004;43:164–170
  29. Bar-Shalom R , Keidar Z , Krausz Y . Prospective image fusion: the role of SPECT/CT and PET/CT . In:  Henkin RE ,  Bova D ,  Dillehay GL , et al. editor. Nuclear Medicine . (ed 2). CV Mosby: St. Louis; 2006;p. 1527–1544
  30. Klein M , Kopelewitz B , Krausz Y , et al.   Contribution of SPECT/CT to bridging between MIBG scan and diagnostic CT . J Nucl Med . 2004;45:361; (abstr)
  31. Schillaci O , Danieli R , Manni C , et al.   Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? . Nucl Med Commun . 2004;25:705–710
  32. Biasotti S , Garaventa A , Villavecchia GP , et al.   False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma . Med Pediatr Oncol 2000 . 2000;35:153–155
  33. Leung A , Shapiro B , Hattner R , et al.   Specificity of radioiodinated MIBG for neural crest tumors in childhood . J Nucl Med . 1997;38:1352–1357
  34. Rufini V , Fisher GA , Shulkin BL , et al.   Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging . J Nucl Med . 1996;37:1464–1468
  35. Gelfand MJ , Elgazzar AH , Kriss VM , et al.   Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors . J Nucl Med . 1994;35:1753–1757
  36. Bonnin F , Lumbroso J , Tenenbaum F , et al.   Refining interpretation of MIBG scans in children . J Nucl Med . 1994;35:803–810
  37. Tang HR , Da Silva AJ , Matthay KK , et al.   Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG . J Nucl Med . 2001;42:237–247
  38. Diehl M , Risse JH , Brandt-Mainz K , et al.   Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study . Eur J Nucl Med . 2001;28:1671–1676
  39. Shapiro B , Rufini V , Jarwan A , et al.   Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131I scans in patients with thyroid cancer . Semin Nucl Med . 2000;30:115–132
  40. Leitha T , Staudenherz A . Frequency of diagnostic dilemmas in 131I whole body scanning . Nuklearmedizin . 2003;42:55–62
  41. Yamamoto Y , Nishiyama Y , Monden T , et al.   Clinical Usefulness of Fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma . J Nucl Med . 2003;44:1905–1910
  42. Krausz Y , Klein M , Uziely B , et al.   Impact of SPECT/CT on assessment of 131I-avid sites in differentiated thyroid cancer . J Nucl Med . 2004;45:349; (abstr)
  43. Ruf J , Lehmkuhl L , Bertram H , et al.   Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma . Nucl Med Commun . 2004;25:1177–1182
  44. Tharp K , Israel O , Hausmann J , et al.   Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma . Eur J Nucl Med Mol Imaging . 2004;31:1435–1442
  45. Ljungberg M , Sjogreen K , Liu X , et al.   A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using Monte Carlo simulation . J Nucl Med . 2002;43:1101–1109
  46. Clark OH . How should patients with primary hyperparathyroidism be treated? . J Clin Endocrinol Metab . 2003;88:3011–3014
  47. Bergenfelz A , Lindblom P , Tibblin S , et al.   Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial . Ann Surg . 2002;236:543–551
  48. van Vroonhoven TJ , van Dalen A . Successful minimally invasive surgery in primary hyperparathyroidism after combined preoperative ultrasound and computed tomography imaging . J Intern Med . 1998;243:581–587
  49. Ohshima A , Simizu S , Okido M , et al.   Endoscopic neck surgery: current status for thyroid and parathyroid diseases . Biomed Pharmacother . 2002;56(suppl 1):48s–52s
  50. Medrano C , Hazelrigg SR , Landreneau RJ , et al.   Thoracoscopic resection of ectopic parathyroid glands . Ann Thorac Surg . 2000;69:221–223
  51. Mariani G , Gulec SA , Rubello D , et al.   Preoperative localization and radioguided parathyroid surgery . J Nucl Med . 2003;44:1443–1458
  52. Denham DW , Norman J . Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon’s choice of operative procedure . J Am Coll Surg . 1998;186:293–305
  53. Gotthardt M , Lohmann B , Behr TM , et al.   Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature . World J Surg . 2004;28:100–107
  54. Lumachi F , Ermani M , Basso S , et al.   Localization of parathyroid tumours in the minimally invasive era: which technique should be chosen? (Population-based analysis of 253 patients undergoing parathyroidectomy and factors affecting parathyroid gland detection) . Endocr Relat Cancer . 2001;8:63–69
  55. Arici C , Cheah WK , Ituarte PH , et al.   Can localization studies be used to direct focused parathyroid operations? . Surgery . 2001;129:720–729
  56. Gotway MB , Reddy GP , Webb WR , et al.   Comparison between MR imaging and 99mTc-MIBI scintigraphy in the evaluation of recurrent or persistent hyperparathyroidism . Radiology . 2001;218:783–790
  57. Lorberboym M , Minski I , Macadziob S , et al.   Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma . J Nucl Med . 2003;44:904–908
  58. Rubello D , Casara D , Fiore D , et al.   An ectopic mediastinal parathyroid adenoma accurately located by a single-day imaging protocol of Tc-99m pertechnetate-MIBI subtraction scintigraphy and MIBI-SPECT-computed tomographic image fusion . Clin Nucl Med . 2002;27:186–190
  59. Ng P , Lenzo NP , McCarthy MC , et al.   Ectopic parathyroid adenoma localised with sestamibi SPECT and image-fused computed tomography . Med J Aust . 2003;179:485–487
  60. Profanter C , Prommegger R , Gabriel M , et al.   Computed axial tomography-MIBI image fusion for preoperative localization in primary hyperparathyroidism . Am J Surg . 2004;187:383–387
  61. Profanter C , Wetscher GJ , Gabriel M , et al.   CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism . Surgery . 2004;135:157–162
  62. Kaczirek K , Prager G , Kienast O , et al.   Combined transmission and 99mTc-sestamibi emission tomography for localization of mediastinal parathyroid glands . Nuklearmedizin . 2003;42:220–223
  63. Gayed IW , Kim EE , Broussard WF , et al.   The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia . J Nucl Med . 2005;46:248–252
  64. Krausz Y , Bettman L , Guralnik L , et al.   Tc99m-MIBI SPECT/CT in Primary Hyperparathyroidism . World J Surg . 2006;30:76–83

PII: S0001-2998(06)00022-5

doi: 10.1053/j.semnuclmed.2006.05.002

Seminars in Nuclear Medicine
Volume 36, Issue 4 , Pages 267-274 , October 2006

Article Tools

* Image Usage & Resolution